lecture: 13.3 schitzophrenia

0.0(0)
studied byStudied by 1 person
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/12

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

13 Terms

1
New cards

Symptoms of schizophrenia

Positive (something extra being added)symptoms: 

Presence of unusual behaviors, in excess of typical functioning 

  • Though disorders delusions 

  • Hallucinations 

 

Negative symptoms: 

Absence or decrease in some typical behaviors 

  • Social withdrawal, lack of affect, and reduced motivation 



Cognitive symptoms: 

Cognitive deficits, such as , difficulty sustaining attention, low psychomotor speed, deficits in learning and memory, poor abstract thinking, poor problem solving 



Age of onset of psychotic symptoms: 

  • Between early adolescence and early adulthood peaking at age of 20-25 and more common in males than females 

2
New cards

Examples of schizophrenia symptoms: 

Positive: 

Hallucinations 

Disordered thoughts 

Delusions 

  • Persecution

  • Grandeur 

  • Control 


Negative: 

  • Flat affect 

  • Poverty of speech 

  • Lack of initiative and persistence 

  • Anhedonia 

  • Social withdrawal 


Cognitive: 

  • Difficulty in sustaining attention 

  • Low psychomotor speed 

  • Deficits in learning/memory 

  • Poor abstract thinking 

  • Poor problem solving 

Genetic factors: 

  • Twin and adoption studies indicate the heritability of schizophrenia 

  • Higher rates in monochorionic monozygotic twins 

  • No “schizophrenia gene” but some associated with them 


3
New cards

Schizophrenia: 

Mutations: mutation of the DISC1 gene 


Paternal age: 

  • Children of older fathers are at increased risk 

  • Increase likelihood of mutation 


Epigenetics

4
New cards

Environmental contributions: 

Associated factors: 

  • Season of birth (late winter/ early spring) 

  • Viral epidemics 

  • Vitamin D deficiency 

  • Population density 

  • Substance abuse 

  • Protective factors: limited evidence 



Obstetric complications: 

  • Prenatal malnutrition and stress 

  • Complications of pregnancy 

  • Toxemia 

  • Abnormal fetal development 

  • Labor and delivery complications 



Brain anomalies: ventricular size 

  • People with schizophrenia have increased ventricle size 


5
New cards

Cerebral gray matter: 

  • Decreased gray matter in people with schizophrenia 

  • MRI scans demonstrate the loss of brain volume in a patient with schizophrenia over 10 years. Notice the enlargement of the lateral; ventricles (dark region in the center of the brain)

6
New cards

Dopamine and positive symptoms: 

  • Dopamine hypothesis: positive symptoms of schizophrenia are caused by hyperactivity of dopaminergic synapses in the mesolimbic pathway 

  • Drugs activating as agonists produce and reinforce positive symptoms 

  • Some studies show those diagnosed with schizophrenia release excessive dopamine, brains may contain more dopamine receptors. 

7
New cards

Mesolimbic dopamine pathway: 

  • Overactivity of the mesolimbic pathway leads to positive symptoms 

  • Mesocortical pathway dysfunction leads to negative and cognitive symptoms

8
New cards

Mesolimbic pathway and treatment side effects: 

Long term drug treatment of schizophrenia: 

  • Typical antipsychotics block dopamine activity 

  • Parkisonian symptoms ‘

  • Tardive dyslexia: repetitive involuntary movements 

Mesocortical DA pathway: Negative and cognitive symptoms

9
New cards

Hypofrontality: 

  • Believes to be responsible for negative symptoms 

  • May also be responsible for hyperactivity in the mesolimbic pathways related to positive symptoms 

10
New cards

Role of Glutamate: 

  • Decreased glutamate activity (resulting in hypofrontality) may contribute to negative and positive symptoms 

  • Chronic low doses of glutamate antagonist drugs produce negative and cognitive symptoms 


11
New cards

Mesocortical DA pathway

Negative and cognitive symptoms


Developmental changes

  • DISC1 gene mutation connected to schizophrenia 

  • Abnormalities in the pyramidal neurons in the PFC 


Atypical antipsychotics: 


Increase DA activity in the PFC and reduce it in the mesolimbic system 

  • aripiprazole : parietal agonist at DA receptors  


<p><span>Negative and cognitive symptoms</span></p><p><br></p><p><span>Developmental changes</span></p><ul><li><p><span>DISC1 gene mutation connected to schizophrenia&nbsp;</span></p></li><li><p><span>Abnormalities in the pyramidal neurons in the PFC&nbsp;</span></p></li></ul><p><br></p><p><span>Atypical antipsychotics:&nbsp;</span></p><p><br></p><p><span>Increase DA activity in the PFC and reduce it in the mesolimbic system&nbsp;</span></p><ul><li><p><span>aripiprazole : parietal agonist at DA receptors&nbsp;&nbsp;</span></p></li></ul><p><br></p>
12
New cards

Role of DISC1 in schizophrenia 

  • Abnormalities after puberty lead to behavioral abnormalities 

<ul><li><p><span>Abnormalities after puberty lead to behavioral abnormalities&nbsp;</span></p></li></ul>
13
New cards

Role of D2 receptors

  • increased availability of D2 leads to decrease in inhibitory neurotransmitter expression

<ul><li><p>increased availability of D2 leads to decrease in inhibitory neurotransmitter expression</p></li></ul>